Morphic to Present at the 42nd Annual J.P. Morgan Healthcare Conference

January 3, 2024

https://www.globenewswire.com/news-release/2024/01/03/2803607/0/en/Morphic-to-Present-at-the-42nd-Annual-J-P-Morgan-Healthcare-Conference.html

-Dr. Praveen Tipirneni, returns in full capacity as Chief Executive Officer from medical leave-

WALTHAM, Mass., Jan. 03, 2024 (GLOBE NEWSWIRE) — Morphic Therapeutic (Nasdaq:MORF), a biotechnology company developing a new generation of oral integrin therapies for the treatment of serious chronic diseases, today announced that Praveen Tipirneni, M.D., Chief Executive Officer of Morphic, has returned in full capacity from a previously announced temporary medical leave of absence and will present at the 42nd Annual J.P. Morgan Healthcare Conference on Wednesday, January 10, 2024 at 3:45 PM PT/6:45 PM ET. A live webcast of the presentation will be available on the Investor section of Morphic’s website at www.morphictx.com. An archived replay will be available on the company’s website following the conference.

Read more at globenewswire.com

Related news for (MORF)

    NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.